Back to Results
First PageMeta Content
University of Texas MD Anderson Cancer Center / University of Texas System / GlaxoSmithKline / Texas Medical Center / Daniel Von Hoff / M. D. Anderson Cancer Center Orlando / Medicine / Cancer organizations / Oncologists


GlaxoSmithKline, M. D. Anderson Formalize Collaboration in Cancer Research New Alliance to Enhance Integration of Basic Science, Clinical Research M. D. Anderson News ReleaseTwo international leaders in cancer
Add to Reading List

Document Date: 2015-05-10 06:41:56

Open Document

File Size: 153,77 KB

Share Result on Facebook

City

Houston / /

Company

GlaxoSmithKline / M. D. Anderson Cancer Center / M. D. Anderson / /

Continent

America / /

Event

Business Partnership / /

Facility

GSK Oncology Medicine Development Center / ABOUT THE UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER Marking / Texas Medical Center / The University of Texas M. D. Anderson Cancer Center / /

IndustryTerm

healthcare / diagnostic and imaging products / research-based pharmaceutical / /

MedicalCondition

nation's top two cancer / cancer / disease / /

Organization

University of Texas M. D. Anderson Cancer Center / GSK Oncology Medicine Development Center / New Alliance / UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER Marking / Texas Medical Center / /

Person

Clet Niyikiza / Paolo Paoletti / Robert Bast / /

Position

senior vice president and head / vice president for translational research / vice president of strategic asset management and biomarker research program / /

PublishedMedium

U.S. News & World Report / /

Technology

drug development / /

SocialTag